Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole SIE vs Femara in HR+/HER2- Advanced Breast Cancer
NCT07340658Phase 3Not yet recruiting
- Sponsor
- Laboratorios Farmacéuticos ROVI
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of letrozole in breast cancer, sponsored by Laboratorios Farmacéuticos ROVI. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07340658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340658.